Blinklab (ASX:BB1)
ASX announcement history & article coverage
Transparent by design.
Announcments by Blinklab (ASX:BB1) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Section 708A Notice
Notification regarding unquoted securities - BB1
Application for quotation of securities - BB1
Application for quotation of securities - BB1
Notification regarding unquoted securities - BB1
European ADHD Study Update
Results of General Meeting
BB1 Granted Foundational U.S. Patent
BB1 Partners with ESPOCH on Large-Scale Multicenter Program
Letter to Shareholders & Proxy Form
Notice of General Meeting & Proxy Form
Therapy Evaluation for Neurodevelopmental Conditions
BB1 to present at Stocks in the Vines Investor Access Day
Quarterly Activities/Appendix 4C Cash Flow Report
BlinkLab advances FDA autism trial, launches Morocco screening program, raises A$17.7M for growth
Section 708A Notice
Application for quotation of securities - BB1
BlinkLab Invited to Present at Ignite Investment Summits
Update - Proposed issue of securities - BB1
Proposed issue of securities - BB1
BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid
BlinkLab Raises A$17.5M to Advance Autism and ADHD Diagnostic Platforms
Trading Halt